Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two adjacent groups of midbrain dopaminergic neurons, A9 (substantia nigra pars compacta) and A10 (ventral tegmental area), have distinct projections and exhibit differential vulnerability in
Parkinson's disease
. Little is known about transcription factors that influence midbrain dopaminergic subgroup phenotypes or their potential role in disease. Here, we demonstrate elevated expression of the transcription factor
orthodenticle homeobox 2
in A10 dopaminergic neurons of embryonic and adult mouse, primate and human midbrain. Overexpression of
orthodenticle homeobox 2
using lentivirus increased levels of known A10 elevated genes, including neuropilin 1, neuropilin 2, slit2 and adenylyl cyclase-activating peptide in both MN9D cells and ventral mesencephalic cultures, whereas knockdown of endogenous
orthodenticle homeobox 2
levels via short hairpin RNA reduced expression of these genes in ventral mesencephalic cultures. Lack of
orthodenticle homeobox 2
in the ventral mesencephalon of
orthodenticle homeobox 2
conditional knockout mice caused a reduction of midbrain dopaminergic neurons and selective loss of A10 dopaminergic projections. Orthodenticle homeobox 2 overexpression protected dopaminergic neurons in ventral mesencephalic cultures from
Parkinson's disease
-relevant toxin, 1-methyl-4-phenylpyridinium, whereas downregulation of
orthodenticle homeobox 2
using short hairpin RNA increased their susceptibility. These results show that
orthodenticle homeobox 2
is important for establishing subgroup phenotypes of post-mitotic midbrain dopaminergic neurons and may alter neuronal vulnerability.
...
PMID:The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons. 2057 4
Recent studies suggest a variety of factors characterize substantia nigra neurons vulnerable to
Parkinson's disease
, including the transcription factors pituitary homeobox 3 (Pitx3) and
orthodenticle homeobox 2
(Otx2) and the trophic factor receptor deleted in colorectal cancer (DCC), but there is limited information on their expression and localization in adult humans. Pitx3, Otx2, and DCC were immunohistochemically localized in the upper brainstem of adult humans and mice and protein expression assessed using relative intensity measures and online microarray data. Pitx3 was present and highly expressed in most dopamine neurons. Surprisingly, in our elderly subjects no Otx2 immunoreactivity was detected in dopamine neurons, although Otx2 gene expression was found in younger cases. Enhanced DCC gene expression occurred in the substantia nigra, and higher amounts of DCC protein characterized vulnerable ventral nigral dopamine neurons. Our data show that, at the age when
Parkinson's disease
typically occurs, there are no significant differences in the expression of transcription factors in brainstem dopamine neurons, but those most vulnerable to
Parkinson's disease
rely more on the trophic factor receptor DCC than other brainstem dopamine neurons.
...
PMID:Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease. 2292 68